Schmidt Karsten, Bhakdisongkhram Sukanya, Uhle Florian, Philipsenburg Christoph, Zivkovic Aleksandar R, Brenner Thorsten, Motsch Johann, Weigand Markus A, Hofer Stefan
Department of Anesthesiology, Heidelberg University Hospital, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
Clinic for Anesthesiology, Intensive Care and Emergency Medicine I, Westpfalz Hospital, Hellmut-Hartert-Str. 1, 67655 Kaiserslautern, Germany.
Data Brief. 2017 Sep 23;15:228-233. doi: 10.1016/j.dib.2017.09.045. eCollection 2017 Dec.
This article contains animal experimental data associated with the research article entitled "GTS-21 reduces microvascular permeability during experimental endotoxemia" (Schmidt et al., 2017) [1] (supplementary datasets of baseline intravital microscopic measurements, baseline TNF-α levels and vital parameters of the evaluated experimental groups are provided). Beneficial anti-inflammatory effects of cholinergic mediators on microvascular inflammation have been demonstrated by intravital microscopic investigations (Schmidt et al., 2015) [2], therefore we evaluated the effect of the cholinergic mediator GTS-21 on microcirculatory alterations during endotoxemia [1]. The data regarding microcirculatory effects of GTS-21 treatment ((3-(2,4-Dimethoxybenzylidene)-anabaseine dihydrochloride; 1 mg/kg; i.v.) in non-endotoxemic animals are presented in this article.
本文包含与题为《GTS-21降低实验性内毒素血症期间的微血管通透性》(施密特等人,2017年)[1]的研究文章相关的动物实验数据(提供了评估实验组的基线活体显微镜测量、基线TNF-α水平和生命体征参数的补充数据集)。活体显微镜研究已证明胆碱能介质对微血管炎症具有有益的抗炎作用(施密特等人,2015年)[2],因此我们评估了胆碱能介质GTS-21对内毒素血症期间微循环改变的影响[1]。本文展示了GTS-21治疗((3-(2,4-二甲氧基亚苄基)-无叶豆碱二盐酸盐;1mg/kg;静脉注射)对非内毒素血症动物微循环影响的数据。